Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Raloxifene | hsa00030 | Pentose phosphate pathway | 1.08E-05 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Raloxifene | hsa00190 | Oxidative phosphorylation | 1.17E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Raloxifene | hsa00220 | Arginine biosynthesis | 6.31E-05 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Raloxifene | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Raloxifene | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.97E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Raloxifene | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Raloxifene | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Raloxifene | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Raloxifene | hsa00330 | Arginine and proline metabolism | 4.10E-02 | 1 | P17707 | AMD1 | More | | Raloxifene | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | | Raloxifene | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Raloxifene | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Raloxifene | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Raloxifene | hsa00565 | Ether lipid metabolism | 3.94E-02 | 1 | Q8N661 | TMEM86B | More | | Raloxifene | hsa00600 | Sphingolipid metabolism | 3.36E-03 | 5 | P07602, Q9BX95, Q13510, O14494, P06280 | PSAP, SGPP1, ASAH1, PLPP1, GLA | More | | Raloxifene | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.21E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Raloxifene | hsa00670 | One carbon pool by folate | 3.91E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Raloxifene | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Raloxifene | hsa00790 | Folate biosynthesis | 7.01E-03 | 2 | Q92820, P05186 | GGH, ALPL | More | | Raloxifene | hsa00830 | Retinol metabolism | 4.10E-02 | 1 | P00325 | ADH1B | More | | Raloxifene | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Raloxifene | hsa00910 | Nitrogen metabolism | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Raloxifene | hsa01100 | Metabolic pathways | 3.37E-02 | 36 | P05089, Q9UJ14, P15104, O14986, P48426, Q14642, Q96DU7, P07195, Q08828, Q02153, Q16875, O43286, O43451, Q86XP1, Q14739, Q9UHK6, P11511, Q86VZ5, Q08477, P15907, Q9UNP4, Q9H4F1, P32321, P60891, P49448, P15586, P00352, Q9BPW9, P43490, P46976, P05166, P13073, P05496, O15239, O15047, Q9NVH6 | ARG1, GGTL3, GLUL, PIP5K1B, PIP4K2A, INPP5A, ITPKC, LDHB, ADCY1, GUCY1B3, PFKFB3, B4GALT5, MGAM, DGKH, LBR, AMACR, CYP19A1, SGMS1, CYP4F3, ST6GAL1, ST3GAL5, ST6GALNAC4, DCTD, PRPS1, GLUD2, GNS, ALDH1A1, DHRS9, PBEF1, GYG1, PCCB, COX4I1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05089 | ARG1 | Arginase-1 | 0.826 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.769 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15104 | GLUL | Glutamine synthetase | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O14986 | PIP5K1B | Phosphatidylinositol 4-phosphate 5-kinase type-1 beta | 0.806 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.725 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14642 | INPP5A | Inositol polyphosphate-5-phosphatase A | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | -0.816 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P07195 | LDHB | L-lactate dehydrogenase B chain | -0.75 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.785 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.861 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43451 | MGAM | Maltase-glucoamylase | 0.745 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.757 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14739 | LBR | Delta(14)-sterol reductase LBR | 0.73 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.736 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P11511 | CYP19A1 | Aromatase | -0.706 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.733 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.832 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.936 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P32321 | DCTD | Deoxycytidylate deaminase | -0.774 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | -0.769 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | -0.895 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15586 | GNS | N-acetylglucosamine-6-sulfatase | 0.716 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | -0.808 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.821 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.749 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P46976 | GYG1 | Glycogenin-1 | 0.845 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | 0.781 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.713 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.745 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | 0.809 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.719 |
| Raloxifene | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Raloxifene | hsa01230 | Biosynthesis of amino acids | 2.22E-03 | 4 | P51854, P60891, Q99707, P37837 | TKTL1, PRPS1, MTR, TALDO1 | More | | Raloxifene | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Raloxifene | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Raloxifene | hsa03013 | RNA transport | 5.41E-06 | 15 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, P78345, Q14240, P23588, Q9Y6A5, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, RPP38, EIF4A2, EIF4B, TACC3, FXR1 | More | | Raloxifene | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Raloxifene | hsa03040 | Spliceosome | 1.08E-02 | 7 | Q14562, O43143, O60508, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, SFRS1, SFRS2, SFRS5, HSPA8 | More | | Raloxifene | hsa04014 | Ras signaling pathway | 8.66E-03 | 7 | Q9NRA1, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PDGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Raloxifene | hsa04060 | Cytokine-cytokine receptor interaction | 4.33E-02 | 11 | P27930, P14778, P01584, Q13651, Q9HBE5, Q9UBD3, P47992, P09341, P32248, P18510, P01730 | IL1R2, IL1R1, IL1B, IL10RA, IL21R, XCL2, XCL1, CXCL1, CCR7, IL1RN, CD4 | More | | Raloxifene | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Raloxifene | hsa04062 | Chemokine signaling pathway | 1.17E-04 | 14 | P25024, P25025, P09341, P19875, P07948, P42338, P19174, P62873, P63218, P50151, Q13009, P14598, P42224, P25963 | CXCR1, CXCR2, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, TIAM1, NCF1, STAT1, NFKBIA | More | | Raloxifene | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Raloxifene | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Raloxifene | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 4 | P21453, Q9H228, P01375, Q13362 | S1PR1, EDG8, TNF, PPP2R5C | More | | Raloxifene | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Raloxifene | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Raloxifene | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Raloxifene | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Raloxifene | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Raloxifene | hsa04141 | Protein processing in endoplasmic reticulum | 8.60E-03 | 6 | P30101, P60604, P11142, P08238, Q9H173, Q9UNL2 | PDIA3, UBE2G2, HSPA8, HSP90AB1, SIL1, SSR3 | More | | Raloxifene | hsa04145 | Phagosome | 6.18E-06 | 13 | P11215, P60709, Q15075, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | ITGAM, ACTB, EEA1, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Raloxifene | hsa04151 | PI3K-Akt signaling pathway | 3.43E-03 | 20 | P21860, P43657, P01106, P27348, P09603, O14944, Q9GZP0, P07900, P62873, P63218, P50151, P13612, P26012, O15335, P24821, Q16363, Q13751, P22105, Q99941, P18848 | ERBB3, P2RY5, MYC, YWHAQ, CSF1, EREG, PDGFD, HSP90AA1, GNB1, GNG5, GNG10, ITGA4, ITGB8, CHAD, TNC, LAMA4, LAMB3, TNXB, CREBL1, ATF4 | More | | Raloxifene | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Raloxifene | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Raloxifene | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | | Raloxifene | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | | Raloxifene | hsa04270 | Vascular smooth muscle contraction | 2.01E-02 | 3 | P0DP24, P35579, P35318 | CALM2, MYH9, ADM | More | | Raloxifene | hsa04371 | Apelin signaling pathway | 7.95E-04 | 7 | P62873, P63218, P50151, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD3, CALM1 | More | | Raloxifene | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Raloxifene | hsa04512 | ECM-receptor interaction | 5.80E-03 | 7 | Q16363, Q13751, P24821, P22105, P13612, P26012, O15335 | LAMA4, LAMB3, TNC, TNXB, ITGA4, ITGB8, CHAD | More | | Raloxifene | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | | Raloxifene | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Raloxifene | hsa04612 | Antigen processing and presentation | 1.07E-03 | 6 | Q14953, P26715, P26717, Q13241, P01732, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Raloxifene | hsa04613 | Neutrophil extracellular trap formation | 4.20E-02 | 5 | P04908, Q93077, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | | Raloxifene | hsa04623 | Cytosolic DNA-sensing pathway | 2.59E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Raloxifene | hsa04640 | Hematopoietic cell lineage | 3.03E-04 | 12 | P13612, P14778, P27930, P11215, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01584 | ITGA4, IL1R1, IL1R2, ITGAM, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, IL1B | More | | Raloxifene | hsa04650 | Natural killer cell mediated cytotoxicity | 5.49E-06 | 12 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, P26717, Q14953, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, KLRC2, KIR2DS5, KLRC1 | More | | Raloxifene | hsa04657 | IL-17 signaling pathway | 2.41E-02 | 4 | P19875, P14780, P80188, P01375 | CXCL2, MMP9, LCN2, TNF | More | | Raloxifene | hsa04658 | Th1 and Th2 cell differentiation | 3.78E-07 | 13 | Q04759, P07766, P20963, P09693, P19174, P01730, P06239, P23771, Q9UL17, P14784, P46531, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, CD4, LCK, GATA3, TBX21, IL2RB, NOTCH1, HLA-DOB, RUNX3 | More | | Raloxifene | hsa04659 | Th17 cell differentiation | 2.26E-09 | 20 | P25963, Q04759, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P84022, Q13485, P01584, P07900, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD3, SMAD4, IL1B, HSP90AA1, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.728 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q04759 | PRKCQ | Protein kinase C theta type | -0.878 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.842 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P06239 | LCK | Tyrosine-protein kinase Lck | -0.856 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.791 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.719 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.715 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.815 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.798 | O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.769 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | O75469 | NR1I2 | Nuclear receptor subfamily 1 group I member 2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.721 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P01584 | IL1B | Interleukin-1 beta | 0.702 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.771 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.877 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.826 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.882 |
| Raloxifene | hsa04660 | T cell receptor signaling pathway | 5.43E-05 | 12 | Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239 | PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK | More | | Raloxifene | hsa04664 | Fc epsilon RI signaling pathway | 6.97E-03 | 4 | P04141, P07948, P19174, P09917 | CSF2, LYN, PLCG1, ALOX5 | More | | Raloxifene | hsa04666 | Fc gamma R-mediated phagocytosis | 2.42E-02 | 5 | P23528, P06396, O14494, P14598, P17252 | CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Raloxifene | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | | Raloxifene | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Raloxifene | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Raloxifene | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Raloxifene | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Raloxifene | hsa04724 | Glutamatergic synapse | 3.88E-04 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | | Raloxifene | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Raloxifene | hsa04727 | GABAergic synapse | 2.40E-04 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Raloxifene | hsa04730 | Long-term depression | 3.34E-03 | 2 | Q14344, P07948 | GNA13, LYN | More | | Raloxifene | hsa04744 | Phototransduction | 2.97E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Raloxifene | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.37E-04 | 8 | P14778, P01584, Q08828, Q13557, P19174, P42338, P24723, Q04759 | IL1R1, IL1B, ADCY1, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Raloxifene | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Raloxifene | hsa04916 | Melanogenesis | 4.80E-02 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Raloxifene | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Raloxifene | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Raloxifene | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | | Raloxifene | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Raloxifene | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | | Raloxifene | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Raloxifene | hsa04934 | Cushing syndrome | 2.63E-02 | 6 | Q99941, P18848, Q08828, O15169, Q13557, O00170 | CREBL1, ATF4, ADCY1, AXIN1, CAMK2D, AIP | More | | Raloxifene | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Raloxifene | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.10E-02 | 1 | O00141 | SGK | More | | Raloxifene | hsa04970 | Salivary secretion | 1.91E-02 | 3 | P07550, P22694, P49913 | ADRB2, PRKACB, CAMP | More | | Raloxifene | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Raloxifene | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Raloxifene | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Raloxifene | hsa05010 | Alzheimer disease | 4.39E-02 | 6 | O15399, Q9NZJ5, Q13564, Q71U36, P09603, P21796 | GRIN2D, EIF2AK3, APPBP1, TUBA1A, CSF1, VDAC1 | More | | Raloxifene | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | | Raloxifene | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | | Raloxifene | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | | Raloxifene | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | | Raloxifene | hsa05032 | Morphine addiction | 7.62E-04 | 6 | P62873, P63218, P50151, Q13370, Q07343, P43250 | GNB1, GNG5, GNG10, PDE3B, PDE4B, GRK6 | More | | Raloxifene | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Raloxifene | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 7.88E-05 | 8 | P25963, Q13488, P09341, P19875, P19174, P25024, P25025, P07948 | NFKBIA, TCIRG1, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Raloxifene | hsa05130 | Pathogenic Escherichia coli infection | 3.19E-02 | 6 | Q71U36, P16333, Q13509, P68371, Q14344, P25963 | TUBA1A, NCK1, TUBB3, TUBB2C, GNA13, NFKBIA | More | | Raloxifene | hsa05132 | Salmonella infection | 3.14E-04 | 14 | P51617, P25963, P08238, Q9UJU2, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, LEF1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Raloxifene | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Raloxifene | hsa05134 | Legionellosis | 1.49E-03 | 5 | P25963, P11215, P11142, P09341, P19875 | NFKBIA, ITGAM, HSPA8, CXCL1, CXCL2 | More | | Raloxifene | hsa05140 | Leishmaniasis | 5.98E-03 | 6 | P14598, P11215, P42224, P25963, P29350, Q15080 | NCF1, ITGAM, STAT1, NFKBIA, PTPN6, NCF4 | More | | Raloxifene | hsa05143 | African trypanosomiasis | 3.01E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Raloxifene | hsa05144 | Malaria | 1.91E-02 | 3 | P01375, P35443, P26718 | TNF, THBS4, KLRK1 | More | | Raloxifene | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Raloxifene | hsa05146 | Amoebiasis | 1.69E-08 | 15 | P01584, Q16363, P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P30679, Q08828, P22694, P12814, P08311 | IL1B, LAMA4, CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, GNA15, ADCY1, PRKACB, ACTN1, CTSG | More | | Raloxifene | hsa05152 | Tuberculosis | 5.68E-03 | 9 | Q13488, P0DP23, P48382, O60603, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Raloxifene | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Raloxifene | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Raloxifene | hsa05163 | Human cytomegalovirus infection | 2.56E-03 | 8 | P25963, P62873, P63218, P50151, P0DP23, Q14344, P30101, P01568 | NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, PDIA3, IFNA21 | More | | Raloxifene | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.62E-05 | 10 | P01568, P42224, P25963, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | | Raloxifene | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | | Raloxifene | hsa05170 | Human immunodeficiency virus 1 infection | 2.58E-04 | 17 | P62873, P63218, P50151, P0DP23, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, P19174, P23528, P10415, Q93034, Q9Y6Q5 | GNB1, GNG5, GNG10, CALM1, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, PLCG1, CFL1, BCL2, CUL5, AP1M2 | More | | Raloxifene | hsa05200 | Pathways in cancer | 1.99E-03 | 15 | P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Raloxifene | hsa05202 | Transcriptional misregulation in cancer | 3.51E-02 | 11 | Q12778, Q15532, P14780, P14923, Q16548, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0 | FOXO1, SS18, MMP9, JUP, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B | More | | Raloxifene | hsa05205 | Proteoglycans in cancer | 1.39E-03 | 13 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P01375, P23588, P04628, Q13635, P22694, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, TNF, EIF4B, WNT1, PTCH1, PRKACB, CD63 | More | | Raloxifene | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Raloxifene | hsa05212 | Pancreatic cancer | 4.70E-03 | 4 | P42224, P84022, Q13485, O75293 | STAT1, SMAD3, SMAD4, GADD45B | More | | Raloxifene | hsa05214 | Glioma | 4.75E-02 | 3 | P0DP23, P19174, O75293 | CALM1, PLCG1, GADD45B | More | | Raloxifene | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Raloxifene | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Raloxifene | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | | Raloxifene | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Raloxifene | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | | Raloxifene | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.62E-04 | 9 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, CD4 | More | | Raloxifene | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Raloxifene | hsa05321 | Inflammatory bowel disease | 3.20E-03 | 7 | P01375, P13765, Q14765, Q9UL17, P23771, P01584, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, GATA3, IL1B, IL21R | More | | Raloxifene | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Raloxifene | hsa05332 | Graft-versus-host disease | 7.27E-04 | 4 | P48023, P01375, P26715, Q13241 | FASLG, TNF, KLRC1, KLRD1 | More | | Raloxifene | hsa05340 | Primary immunodeficiency | 3.99E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Raloxifene | hsa05415 | Diabetic cardiomyopathy | 2.18E-03 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | |